Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie Grabar

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 28, 2016
Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patientsYann-Erick Claessens, Eloise Trabattoni, Sophie Grabar, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 21, 2011
Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis?Solweig Guinard-Barbier, Sophie Grabar, Camille Chenevier-Gobeaux, et al.
International Journal of Cancer|November 20, 2025
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIVSophie Grabar, Paula Lakrout, Valérie Potard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohortMira Hleyhel, Aurélien Belot, Anne Marie Bouvier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North AmericaEnrico Girardi, Caroline A Sabin, Antonella d'Arminio Monforte, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
AIDS (London, England)|December 1, 2012
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapyJean-Marc Lacombe, François Boue, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 28, 2016
Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patientsYann-Erick Claessens, Eloise Trabattoni, Sophie Grabar, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|May 21, 2011
Is mid-regional pro-atrial natriuretic peptide (MRproANP) an accurate marker of bacteremia in pyelonephritis?Solweig Guinard-Barbier, Sophie Grabar, Camille Chenevier-Gobeaux, et al.
International Journal of Cancer|November 20, 2025
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIVSophie Grabar, Paula Lakrout, Valérie Potard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 2013
Risk of AIDS-defining cancers among HIV-1-infected patients in France between 1992 and 2009: results from the FHDH-ANRS CO4 cohortMira Hleyhel, Aurélien Belot, Anne Marie Bouvier, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2005
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North AmericaEnrico Girardi, Caroline A Sabin, Antonella d'Arminio Monforte, et al.
Plos One|November 1, 2018
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in FranceLaure-Amélie de Monteynard, Sophie Matheron, Sophie Grabar, et al.
Plos One|March 4, 2015
Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in FranceLaure-Amélie de Monteynard, Rosemary Dray-Spira, Pierre de Truchis, et al.
The Journal of Clinical Endocrinology and Metabolism|March 19, 2009
Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypesJérôme Bertherat, Anélia Horvath, Lionel Groussin, et al.
AIDS (London, England)|December 1, 2012
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapyJean-Marc Lacombe, François Boue, Sophie Grabar, et al.
AIDS (London, England)|July 19, 2016
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in FranceLaure-Amélie de Monteynard, Sophie Matheron, Jacques Gilquin, et al.
Pageof 12